-
1دورية أكاديمية
المؤلفون: Breu, Markus1 (AUTHOR), Sandesjö, Fredrik2 (AUTHOR), Milos, Ruxandra‐Iulia3 (AUTHOR), Svoboda, Jan4 (AUTHOR), Salzer, Jonatan5 (AUTHOR), Schneider, Lisa6 (AUTHOR), Reichelt, Julian Benedikt1,7 (AUTHOR), Bertolini, Annikki8 (AUTHOR), Blaschek, Astrid9 (AUTHOR), Fink, Katharina10 (AUTHOR), Höftberger, Romana11,12 (AUTHOR), Lycke, Jan13 (AUTHOR), Rostásy, Kevin8 (AUTHOR), Seidl, Rainer1 (AUTHOR), Siegert, Sandy1 (AUTHOR), Wickström, Ronny2 (AUTHOR), Kornek, Barbara7,12 (AUTHOR) barbara.kornek@meduniwien.ac.at
المصدر: European Journal of Neurology. May2024, Vol. 31 Issue 5, p1-9. 9p.
مصطلحات موضوعية: *MULTIPLE sclerosis, *MAGNETIC resonance imaging, *RITUXIMAB
-
2دورية أكاديمية
المؤلفون: Pakeerathan, T., Havla, Joachim, Schwake, C., Salmen, A., Bigi, S., Abegg, M., Brügger, D., Ferrazzini, T., Runge, A.-K., Breu, Markus, Kornek, B., Bsteh, G., Felipe-Rucián, Ana, Ringelstein, M., Aktas, Orhan, Karenfort, M., Wendel, E., Kleiter, I., Hellwig, K., Kümpfel, Tania, Thiels, C., Lücke, T., Gold, R., Rostasy, K., Ayzenberg, I., Universitat Autònoma de Barcelona
مصطلحات موضوعية: Optical coherence tomography, Visual evoked potential, Optic neuritis, Myelin-oligodendrocyte-glycoprotein IgG, MOGAD, Multiple sclerosis, Pediatric patients, Children
وصف الملف: application/pdf
العلاقة: Journal of Neurology; Vol. 269 (july 2022), p. 6366-6376; https://ddd.uab.cat/record/268226Test; urn:10.1007/s00415-022-11256-y; urn:oai:ddd.uab.cat:268226; urn:pmcid:PMC9618526; urn:pmc-uid:9618526; urn:pmid:35869995; urn:oai:pubmedcentral.nih.gov:9618526; urn:articleid:14321459v269p6366
-
3دورية أكاديمية
المؤلفون: Breu, Markus1 (AUTHOR) markus.breu@meduniwien.ac.at, Lechner, Christian2 (AUTHOR), Schneider, Lisa3 (AUTHOR), Tobudic, Selma3 (AUTHOR), Winkler, Stefan3 (AUTHOR), Siegert, Sandy1 (AUTHOR), Baumann, Matthias2 (AUTHOR), Seidl, Rainer1 (AUTHOR), Berger, Thomas4 (AUTHOR), Kornek, Barbara4 (AUTHOR)
المصدر: Pediatric Neurology. Jun2023, Vol. 143, p19-25. 7p.
مصطلحات موضوعية: *HUMORAL immunity, *MULTIPLE sclerosis, *VACCINE effectiveness, *SARS-CoV-2, *VACCINATION, *HIV seroconversion, *JOHN Cunningham virus